These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


125 related items for PubMed ID: 3841806

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Changes in nociception after intrathecal administration of 5,6-dihydroxytryptamine in mice.
    Fasmer OB, Berge OG, Walther B, Hole K.
    Neuropharmacology; 1983 Oct; 22(10):1197-201. PubMed ID: 6689057
    [Abstract] [Full Text] [Related]

  • 3. Time course of changes in nociception after 5,6-dihydroxytryptamine lesions of descending 5-HT pathways.
    Berge OG, Fasmer OB, Flatmark T, Hole K.
    Pharmacol Biochem Behav; 1983 Apr; 18(4):637-43. PubMed ID: 6867068
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Spinal 5-HT7 receptors play an important role in the antinociceptive and antihyperalgesic effects of tramadol and its metabolite, O-Desmethyltramadol, via activation of descending serotonergic pathways.
    Yanarates O, Dogrul A, Yildirim V, Sahin A, Sizlan A, Seyrek M, Akgül O, Kozak O, Kurt E, Aypar U.
    Anesthesiology; 2010 Mar; 112(3):696-710. PubMed ID: 20179508
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Noradrenergic-serotonergic interactions and nociception in the rat.
    Archer T, Jonsson G, Minor BG, Post C.
    Eur J Pharmacol; 1986 Jan 29; 120(3):295-307. PubMed ID: 3081358
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lesions of bulbo-spinal serotonergic or noradrenergic pathways reduce nociception as measured by the formalin test.
    Tjølsen A, Berge OG, Hole K.
    Acta Physiol Scand; 1991 Jun 29; 142(2):229-36. PubMed ID: 1877371
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Involvement of spinal serotonergic pathways in nociception but not in avoidance learning.
    Ogren SO, Berge OG, Johansson C.
    Psychopharmacology (Berl); 1985 Jun 29; 87(3):260-5. PubMed ID: 3001802
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sex-related differences in descending norepinephrine and serotonin controls of spinal withdrawal reflex during intramuscular saline induced muscle nociception in rats.
    Lei J, Jin L, Zhao Y, Sui MY, Huang L, Tan YX, Chen YK, You HJ.
    Exp Neurol; 2011 Apr 29; 228(2):206-14. PubMed ID: 21238453
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Involvement of central serotonergic pathways in nefopam-induced antinociception.
    Hunskaar S, Fasmer OB, Broch OJ, Hole K.
    Eur J Pharmacol; 1987 Jun 12; 138(1):77-82. PubMed ID: 2442003
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.